Signaling pathways
- BA2731 IberdomideSummary: Iberdomide (CC-220) is an orally effective (CRBN) E3 ligase modulator.
- BA2732 IsoginkgetinSummary: Isoginkgetin is an inhibitor.
- BA2733 WM-3835Summary: WM-3835 is a potent, highly specific(or) inhibitor.
- BA2734 RaptinalSummary: Direct activation of Raptinal initiates apoptosis-dependent endogenous pathways.
- BA2735 HA15Summary: HA15 is a potent and specific inhibitor of endoplasmic reticulum chaperonin.
- BA2736 TakinibSummary: Takinib (EDHS-206) is a potent and selective inhibitor (=9.5nM)
- BA2737 MetoprololSummary: Metoprolol is an orally active, selective beta1-adrenoceptor antagonist.
- BA2738 DB2313Summary: DB2313 is a potent inhibitor of transcription factors.
- BA2739 ACBI1Summary: ACBI1 is a potent, technology-based BAFATPase subunit and degrader.
- BA2740 3BDOSummary: 3BDO is a new type of activator.